AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27710006 — intervention group
Group type: COMPARATOR
Intervention: Waitlist comparison group
Number of subjects: 115
Study 25556770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools with new meal pattern (students could select one fruit and two vegetable servings per reimbursable meal)
Number of subjects: 1576
Study 25556770 — intervention group
Group type: COMPARATOR
Intervention: Control schools with previous meal pattern (students could select a total of two fruit and vegetable servings per meal)
Number of subjects: 1576
Study 24462850 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 45
Study 24462850 — intervention group
Group type: EXPERIMENTAL
Intervention: HALO PKS cutting forceps
Number of subjects: 45
Study 24462850 — intervention group
Group type: EXPERIMENTAL
Intervention: ENSEAL tissue sealer
Number of subjects: 45
Study 23116189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dil Mil intervention plus standard care
Number of subjects: 0
Study 23116189 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 20229041 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of E. coli lipopolysaccharide (LPS) at a dosage of 0.3 ng/kg
Number of subjects: 42
Study 20229041 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of E. coli lipopolysaccharide (LPS)
Number of subjects: 42
Study 17504848 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with combined primary posterior capsulorhexis (PPC) and posterior optic buttonholing (POBH)
Number of subjects: 50
Study 17504848 — intervention group
Group type: COMPARATOR
Intervention: Conventional in‐the‐bag IOL implantation
Number of subjects: 50
Study 16326367 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental and behavioral interventions (EBI) during weighing procedures
Number of subjects: 45
Study 16326367 — intervention group
Group type: COMPARATOR
Intervention: Control (without EBI) during weighing procedures
Number of subjects: 45
Study 12053830 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy for multiple sclerosis
Number of subjects: 0
Study 12053830 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy for Parkinson's disease
Number of subjects: 0
Study 10463897 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 483
Study 10463897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg twice daily
Number of subjects: 483
Study 10463897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study 8778004 — intervention group
Group type: EXPERIMENTAL
Intervention: Self placental antigens (SPA) reactivity assessed by leucocyte‐migration inhibition assay
Number of subjects: 27
Study 8778004 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-fetal lymphocyte cytotoxic antibodies (AFCA) detection using complement dependent microcytotoxicity assay
Number of subjects: 27
Study 3149202 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (10 mg intravenous bolus followed by 2.5 mg/h continuous infusion)
Number of subjects: 11
Study 3149202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 29562853 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual cognitive remediation
Number of subjects: 51
Study 29562853 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 51
Study 29562853 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 51
Study 31634738 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care (internet CBT with telephone support)
Number of subjects: 270
Study 31634738 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care
Number of subjects: 270
Study 31634738 — intervention group
Group type: COMPARATOR
Intervention: tCBT
Number of subjects: 270
Study 28877913 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/d
Number of subjects: 5529
Study 28877913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5529
Study 26582116 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise using electric stimulation and biofeedback
Number of subjects: 30
Study 26582116 — intervention group
Group type: COMPARATOR
Intervention: Self pelvic floor muscle exercise
Number of subjects: 30
Study 23782962 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu-50 (0.5 ml)
Number of subjects: 3320
Study 23782962 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu-25 (0.25 ml)
Number of subjects: 3320
Study 23782962 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine (Fluzone®; 0.25 ml)
Number of subjects: 3320
Study 23782962 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu-25
Number of subjects: 3320
Study 23782962 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu-50
Number of subjects: 3320
Study 23782962 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 3320
Study 21186077 — intervention group
Group type: EXPERIMENTAL
Intervention: NSS (Nephron‐sparing surgery)
Number of subjects: 541
Study 21186077 — intervention group
Group type: COMPARATOR
Intervention: RN (Radical nephrectomy)
Number of subjects: 541
Study 21186077 — intervention group
Group type: EXPERIMENTAL
Intervention: NSS
Number of subjects: 541
Study 21186077 — intervention group
Group type: COMPARATOR
Intervention: RN
Number of subjects: 541
Study 18695440 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide and unfractionated heparin according to the ESPRIT protocol
Number of subjects: 0
Study 18695440 — intervention group
Group type: COMPARATOR
Intervention: Placebo and unfractionated heparin
Number of subjects: 0
Study 20409103 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care, peer counseling, in-home breast milk intake measurement, and postdischarge lactation support
Number of subjects: 310
Study 20409103 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdischarge interventions
Number of subjects: 310
Study 20409103 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postdischarge interventions
Number of subjects: 310
Study 16109110 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (500 mg), Aspirin (500 mg), Caffeine (130 mg)
Number of subjects: 171
Study 16109110 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan (50 mg)
Number of subjects: 171
Study 12097446 — intervention group
Group type: EXPERIMENTAL
Intervention: elmex fluid (10,000 ppm F)
Number of subjects: 0
Study 12097446 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 9495394 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive inotropic drugs (PIDs) including amrinone, dobutamine, epinephrine, or dopamine (≥ 5 microg x kg[‐1] x min[‐1])
Number of subjects: 149
Study 9495394 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive inotropic drugs (PIDs)
Number of subjects: 149
Study 9495394 — intervention group
Group type: COMPARATOR
Intervention: Control (no PIDs)
Number of subjects: 149
Study 7809347 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Complaints Scale (HCS) in 60 subjects participating in cardiac rehabilitation
Number of subjects: 535
Study 7809347 — intervention group
Group type: COMPARATOR
Intervention: Health Complaints Scale (HCS) in 60 control subjects
Number of subjects: 535
Study 3044007 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline 50 mg
Number of subjects: 12
Study 3044007 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline 50 mg
Number of subjects: 12
Study 11250628 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisialagogue (glycopyrrolate)
Number of subjects: 36
Study 11250628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 30606262 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence Project risk of bias tool
Number of subjects: 125
Study 30019500 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-7 alcohol units per week
Number of subjects: 323
Study 30019500 — intervention group
Group type: COMPARATOR
Intervention: <1-3 alcohol units per week
Number of subjects: 323
Study 30019500 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥8 alcohol units per week
Number of subjects: 323
Study 27089361 — intervention group
Group type: COMPARATOR
Intervention: Water and walk (WW)
Number of subjects: 29
Study 27089361 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose and walk (GW)
Number of subjects: 29
Study 27089361 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (G)
Number of subjects: 29
Study 24559015 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of an oral nutritional supplement containing maltodextrine and whey protein, consumed 150 to 210 min before gastroscopy
Number of subjects: 24
Study 24559015 — intervention group
Group type: COMPARATOR
Intervention: No supplement (control group)
Number of subjects: 24
Study 23098412 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg three times daily before and during ascent to 4928 m
Number of subjects: 294
Study 23098412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294
Study 21070615 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (17 standard points with 'de qi' manipulation)
Number of subjects: 42
Study 21070615 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (17 sham points of shallow penetration without manipulation)
Number of subjects: 42
Study 17986746 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC‐AT (Ranitidine Bismuth Citrate 400 mg, Amoxicillin 1000 mg, Tetracycline 500 mg)
Number of subjects: 300
Study 17986746 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC‐AC (Ranitidine Bismuth Citrate 400 mg, Amoxicillin 1000 mg, Clarithromycin 500 mg)
Number of subjects: 300
Study 17986746 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC‐MT (Ranitidine Bismuth Citrate 400 mg, Metronidazole 500 mg, Tetracycline 500 mg)
Number of subjects: 300
Study 17986746 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 300
Study 15295374 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 140
Study 15295374 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone
Number of subjects: 140
Study 11260412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine plus low-dose prednisone
Number of subjects: 51
Study 11260412 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 51
Study 11260412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 51
Study 11260412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 9678816 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subnitrate (300 mg q.d.s.), omeprazole (20 mg b.d.), and amoxycillin (500 mg q.d.s.) for 14 days
Number of subjects: 50
Study 9678816 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (20 mg b.d.) and amoxycillin (500 mg q.d.s.) for 14 days
Number of subjects: 50
Study 9678816 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subnitrate with dual oral therapy
Number of subjects: 50
Study 9678816 — intervention group
Group type: COMPARATOR
Intervention: Dual oral therapy alone
Number of subjects: 50
Study 8305276 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium sulfate
Number of subjects: 36
Study 8305276 — intervention group
Group type: COMPARATOR
Intervention: Nonionic low-osmolar contrast medium
Number of subjects: 36
Study 2972802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue tone or chord heard by subjects to form an image of a tone or chord one whole step in pitch above the cue.
Number of subjects: 0
Study 2972802 — intervention group
Group type: COMPARATOR
Intervention: Random-tone mask used in Experiment 3 to control for echoic memory.
Number of subjects: 0
Study 2972802 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery instructions provided in Experiments 1 and 3.
Number of subjects: 0
Study 2972802 — intervention group
Group type: COMPARATOR
Intervention: Predictions made by subjects in Experiment 2 regarding 'an average person' using imagery.
Number of subjects: 0
Study 2972802 — intervention group
Group type: COMPARATOR
Intervention: Task completed without imagery instructions in Experiment 4.
Number of subjects: 0
Study 31837559 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg once daily (OD) for 6 months, started on day 3 postoperatively
Number of subjects: 10
Study 31837559 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg OD
Number of subjects: 10
Study 29282633 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 1326
Study 29282633 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 1326
Study 29282633 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 1326
Study 29282633 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 1326
Study 29282633 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin and Glimepiride
Number of subjects: 1326
Study 28240608 — intervention group
Group type: EXPERIMENTAL
Intervention: demineralized bone matrix + collagen membrane (CM)
Number of subjects: 17
Study 28240608 — intervention group
Group type: EXPERIMENTAL
Intervention: hydroxyapatite bone substitute (HBS) + CM
Number of subjects: 17
Study 28240608 — intervention group
Group type: EXPERIMENTAL
Intervention: CM
Number of subjects: 17
Study 28240608 — intervention group
Group type: COMPARATOR
Intervention: left empty
Number of subjects: 17
Study 26149987 — intervention group
Group type: EXPERIMENTAL
Intervention: SUBA-itraconazole
Number of subjects: 7
Study 26149987 — intervention group
Group type: COMPARATOR
Intervention: Sporanox
Number of subjects: 7
Study 26149987 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake
Number of subjects: 7
Study 26149987 — intervention group
Group type: COMPARATOR
Intervention: Fasted state
Number of subjects: 7
Study 24130350 — intervention group
Group type: EXPERIMENTAL
Intervention: HCLC followed by SAP therapy (intensive group; N = 48)
Number of subjects: 68
Study 24130350 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group treated with multiple daily injections or insulin pump therapy (N = 20)
Number of subjects: 68
Study 24130350 — intervention group
Group type: EXPERIMENTAL
Intervention: HCLC followed by SAP therapy (intensive group)
Number of subjects: 68
Study 24130350 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 68
Study 20955776 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg twice a day for 5 days)
Number of subjects: 11
Study 20955776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 18300967 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional wounds
Number of subjects: 103
Study 18300967 — intervention group
Group type: EXPERIMENTAL
Intervention: Excisional wounds
Number of subjects: 103
Study 18300967 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteriorly placed incisional scars
Number of subjects: 103
Study 18300967 — intervention group
Group type: EXPERIMENTAL
Intervention: Posteriorly placed excisional scars
Number of subjects: 103
Study 18300967 — intervention group
Group type: EXPERIMENTAL
Intervention: All scars
Number of subjects: 103
Study 16781295 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (1 mg daily)
Number of subjects: 0
Study 16781295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12622663 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation of the subthalamic nucleus (STIM ON)
Number of subjects: 12
Study 12622663 — intervention group
Group type: COMPARATOR
Intervention: Levodopa (MED)
Number of subjects: 12
Study 12622663 — intervention group
Group type: COMPARATOR
Intervention: Deep brain stimulation off (STIM OFF)
Number of subjects: 12
Study 10230169 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated soft drink (CC)
Number of subjects: 8
Study 10230169 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral water (MW)
Number of subjects: 8
Study 10230169 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution (CES)
Number of subjects: 8
Study 10230169 — intervention group
Group type: COMPARATOR
Intervention: Urine color, osmolality and SEC
Number of subjects: 8
Study 8916812 — intervention group
Group type: EXPERIMENTAL
Intervention: Z‐BUF (high-volume, zero‐fluid balance ultrafiltration)
Number of subjects: 20
Study 8916812 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 1884747 — intervention group
Group type: EXPERIMENTAL
Intervention: Rythmodan L.A. 250 mg b.d.
Number of subjects: 10
Study 1884747 — intervention group
Group type: COMPARATOR
Intervention: Dirytmin Durettes 300 mg b.d.
Number of subjects: 10
Study 6819898 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 24
Study 6819898 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride
Number of subjects: 24
Study 6819898 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide and lisuride
Number of subjects: 24
Study 30863044 — intervention group
Group type: EXPERIMENTAL
Intervention: Claims-based predictive model (likely to have undiagnosed COPD)
Number of subjects: 549
Study 30863044 — intervention group
Group type: COMPARATOR
Intervention: Claims-based predictive model (not likely to have undiagnosed COPD)
Number of subjects: 549
Study 30863044 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model performance metrics
Number of subjects: 549
Study 29053808 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-Related Eye Disease Study 2 formulation with a low dose [25 mg] of zinc and an addition of 10 mg meso‐zeaxanthin; n = 60
Number of subjects: 121
Study 29053808 — intervention group
Group type: COMPARATOR
Intervention: Age-Related Eye Disease Study 2 formulation with a low dose [25 mg] of zinc; n = 61
Number of subjects: 121
Study 29053808 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 121
Study 27113126 — intervention group
Group type: EXPERIMENTAL
Intervention: Fastrach/pillowless
Number of subjects: 193
Study 27113126 — intervention group
Group type: COMPARATOR
Intervention: air-Q/pillowless
Number of subjects: 193
Study 27113126 — intervention group
Group type: EXPERIMENTAL
Intervention: Fastrach/head-elevated
Number of subjects: 193
Study 27113126 — intervention group
Group type: COMPARATOR
Intervention: air-Q/head-elevated
Number of subjects: 193
Study 27113126 — intervention group
Group type: EXPERIMENTAL
Intervention: head-elevated position
Number of subjects: 193
Study 24063909 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium butyrate with short-chain fatty acids
Number of subjects: 42
Study 22889693 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 42
Study 22889693 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise
Number of subjects: 42
Study 22889693 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 42
Study 19317825 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity consultation delivered by a person
Number of subjects: 134
Study 19317825 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 134
Study 19317825 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity consultation delivered in written form
Number of subjects: 134
Study 19317825 — intervention group
Group type: COMPARATOR
Intervention: All groups (including both interventions and control)
Number of subjects: 134
Study 17582652 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education prior to discharge
Number of subjects: 588
Study 17582652 — intervention group
Group type: COMPARATOR
Intervention: Non-educated group
Number of subjects: 588
Study 14747781 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA (injectable hormonal contraceptive)
Number of subjects: 140
Study 14747781 — intervention group
Group type: COMPARATOR
Intervention: Control (no contraceptive steroid)
Number of subjects: 140
Study 12659397 — intervention group
Group type: EXPERIMENTAL
Intervention: NuvaRing (15 microgram ethinylestradiol and 120 microgram etonogestrel per day)
Number of subjects: 0
Study 12659397 — intervention group
Group type: EXPERIMENTAL
Intervention: NuvaRing (3 days of use)
Number of subjects: 0
Study 12659397 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed ring insertion (when follicles had developed to 13 mm)
Number of subjects: 0
Study 12659397 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptive (30 microgram ethinylestradiol and 150 microgram desogestrel)
Number of subjects: 0
Study 10910608 — intervention group
Group type: EXPERIMENTAL
Intervention: Local manipulation (massage and hot packing) after vaccinations
Number of subjects: 808
Study 10910608 — intervention group
Group type: EXPERIMENTAL
Intervention: Local manipulation (massage and hot packing) after DTPa vaccinations for two minutes
Number of subjects: 808
Study 10910608 — intervention group
Group type: COMPARATOR
Intervention: Control group (only vaccinations without manipulation)
Number of subjects: 808
Study 7472661 — intervention group
Group type: EXPERIMENTAL
Intervention: Low nitrogen and low calcium diet (0.49 +/- 0.11 g protein/(kg.d), 429 +/- 190 mg calcium/d)
Number of subjects: 15
Study 7472661 — intervention group
Group type: EXPERIMENTAL
Intervention: Low nitrogen and high calcium diet (0.44 +/- 0.08 g protein/(kg.d), 1643 +/- 171 mg calcium/d)
Number of subjects: 15
Study 7472661 — intervention group
Group type: EXPERIMENTAL
Intervention: High nitrogen and high calcium diet (2.71 +/- 0.75 g protein/(kg.d), 1589 +/- 633 mg calcium/d)
Number of subjects: 15
Study 7472661 — intervention group
Group type: COMPARATOR
Intervention: Baseline dietary intake (0.99 +/- 0.51 g protein/(kg.d), 589 +/- 152 mg calcium/d)
Number of subjects: 15
Study 2137497 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 1 (specific method not detailed)
Number of subjects: 21
Study 2137497 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia blanket
Number of subjects: 21
Study 2137497 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 2 (specific method not detailed)
Number of subjects: 21
Study 2137497 — intervention group
Group type: EXPERIMENTAL
Intervention: Method 3 (specific method not detailed)
Number of subjects: 21
Study 6791396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual administration of 1.6 mg of nitroglycerin (Group I)
Number of subjects: 17
Study 6791396 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 17